Klinikum Schwabing

Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article End-to-end privacy preserving deep learning on multi-institutional medical imaging (2021) Kaissis G, Ziller A, Passerat-Palmbach J, Ryffel T, Usynin D, Trask A, Lima I, et al. Journal article Kinetics of renal function during induction in newly diagnosed multiple myeloma: Results of two prospective studies by the german myeloma study group dsmm (2021) Bachmann F, Schreder M, Engelhardt M, Langer C, Wolleschak D, Muegge LO, Duerk H, et al. Journal article Haematological characteristics and spontaneous haematological recovery in Pearson syndrome (2021) Yoshimi A, Gruenert SC, Cario H, Fisch A, Gross-Wieltsch U, Timmermann K, Kontny U, et al. Journal article Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD) (2020) Burgmaier K, Ariceta G, Bald M, Buescher AK, Burgmaier M, Erger F, Gessner M, et al. Journal article Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects (2020) Jansen L, Merz M, Engelhardt M, Weisel K, Scheid C, Straka C, Langer C, et al. Journal article Recurrent Therapy of Multiple Myeloma - Individualized Concepts from the Arsenal of Diverse Options Rezidivtherapie des Multiplen Myeloms - Individualisierte Konzepte aus dem Arsenal vielfältiger Optionen (2020) Weyermann C, Straka C, Einsele H Journal article, Review article High-risk additional chromosomal abnormalities at low blast counts herald death by CML (2020) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Journal article High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels (2019) Hehlmann R, Voskanyan A, Lauseker M, Pfirrmann M, Kalmanti L, Rinaldetti S, Kohlbrenner K, et al. Conference contribution BRAF inhibitor treatment in hairy cell leukemia: a long-term follow up study (2019) Liebers N, Roider T, Bohn JP, Pircher A, Ferstl B, Ebnoether M, Perker M, et al. Conference contribution